Abstract:Background: Acute kidney injury (AKI) is a common and severe complication in patients in the intensive care unit with a significant impact on patient's mortality and morbidity. Therefore renal protective therapy is very important in these severely ill patients. Aim: Several renal protective strategies have been postulated during recent decades, which came from pathophysiologic concepts and have been contradicted or changed during the last few years. So lessons had to be learned in AKI, leading to new, in many cases completely reversed preventive and therapeutic concepts which may also be important for protection in other organs. Recent findings: Most important for renal protection is the early identification of patients at risk for AKI or with acute kidney damage before renal function further deteriorates. A stage-based management of AKI comprises more general measures like discontinuation of the nephrotoxic agent but most importantly early hemodynamic stabilization. Recent research has contradicted that AKI is renal ischemia caused by vasoconstriction with consecutive tubular necrosis. In septic AKI, renal blood flow is even increased. Intrarenal vasodilation together with microcirculatory changes and redistribution of blood flow lead to a drop in glomerular filtration by functional changes. Accordingly it had to be learned that not vasodilators but vasoconstrictors are beneficial in AKI. A mean arterial blood pressure target of >65 mm Hg is often recommended but exact targets are not known, and patients with pre-existing hypertension even need higher perfusion pressure. Also the concept that fluid therapy is always beneficial for the kidney in shock states had to be revised. A volume restrictive therapy with only balanced crystalloids is also becoming more important in AKI. Still no specific pharmacological therapy for renal protection is available. Inflammation and mitochondrial dysfunction appear to play a significant role in AKI. Anti-inflammatory strategies are under investigation and may become more important for AKI prevention and therapy in the future. (This article is freely available.).

Strengthening the standardized treatment of acute kidney injury

Importance of the standardized clinical application and evaluation of renal injury markers

Recent Advances in Engineered Nanomaterials for Acute Kidney Injury Theranostics

Updates in Timing of Initiation of Renal Replacement Therapy in Patients with Acute Kidney Injury

Management of patients at risk of acute kidney injury

Prevention and Early Detection of Acute Kidney Injury in Intensive Care Unit: A Systematic Review

Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)

A Review of Current Approaches and Emerging Innovations

Personalized acute kidney injury treatment

Challenges and Advances in the Treatment of AKI

Biomarkers for Early Diagnosis of Acute Kidney Injury: Current Progress and Clinical prospects.

[Acute Kidney Injury: Epidemiology, Pathophysiology, Repair Mechanisms].

Biotherapy of experimental acute kidney injury: emerging novel therapeutic strategies

Acute Kidney Injury: From Diagnosis to Prevention and Treatment Strategies

[Carboxylic proteinases from the microscopic fungi Trichoderma viride and Trichoderma lignorum].

[Chinese clinical practice guideline for acute kidney injury]

Prevention and Therapy of Acute Kidney Injury in the Developing World

Precision management of acute kidney injury in the intensive care unit: current state of the art

Diagnostics, Risk Factors, Treatment and Outcomes of Acute Kidney Injury in a New Paradigm

Recent Advances in Nanotherapeutics for the Treatment and Prevention of Acute Kidney Injury

Lessons learned from kidney dysfunction : Preventing organ failure